X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5555) 5555
Publication (590) 590
Book Review (121) 121
Report (86) 86
Book Chapter (76) 76
Dissertation (32) 32
Conference Proceeding (23) 23
Government Document (13) 13
Magazine Article (9) 9
Book / eBook (7) 7
Web Resource (4) 4
Newsletter (2) 2
Newspaper Article (2) 2
Data Set (1) 1
Presentation (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3083) 3083
index medicus (3016) 3016
male (1764) 1764
female (1625) 1625
adult (1074) 1074
middle aged (1007) 1007
pharmacology & pharmacy (967) 967
sustained virological response (899) 899
sustained attention (798) 798
gastroenterology & hepatology (791) 791
treatment outcome (771) 771
hepatitis c (744) 744
animals (743) 743
antiviral agents - therapeutic use (723) 723
analysis (642) 642
hepatitis c, chronic - drug therapy (635) 635
hepatitis c virus (606) 606
aged (565) 565
sustained release (565) 565
sustained-release (558) 558
care and treatment (516) 516
neurosciences (502) 502
interferon (482) 482
health aspects (467) 467
psychiatry (441) 441
research (411) 411
drug delivery systems (402) 402
drug therapy, combination (393) 393
hepatitis (384) 384
therapy (382) 382
ribavirin (381) 381
sustained virologic response (381) 381
adolescent (352) 352
studies (340) 340
double-blind (339) 339
young adult (339) 339
drug therapy (337) 337
article (335) 335
time factors (330) 330
management (328) 328
nanoparticles (319) 319
attention (310) 310
hepacivirus - genetics (309) 309
cirrhosis (308) 308
virus-infection (304) 304
liver (302) 302
risk factors (299) 299
performance (292) 292
patients (290) 290
genotype (288) 288
ribavirin - therapeutic use (283) 283
medicine & public health (281) 281
interferon-alpha - therapeutic use (278) 278
drugs (275) 275
child (272) 272
clinical neurology (272) 272
antiviral agents (266) 266
controlled release (265) 265
children (259) 259
hepatocellular-carcinoma (249) 249
psychology (245) 245
retrospective studies (238) 238
infectious diseases (234) 234
clinical trials (230) 230
rats (229) 229
fibrosis (228) 228
delayed-action preparations (227) 227
medicine (226) 226
efficacy (224) 224
sustained response (224) 224
biological response modifiers (222) 222
hepatitis c, chronic - complications (222) 222
sustained-release bupropion (219) 219
hepatitis c, chronic - virology (217) 217
liver cirrhosis (209) 209
sustained competitive advantage (209) 209
antiviral agents - administration & dosage (207) 207
hcv (205) 205
neuropsychological tests (205) 205
usage (205) 205
antiviral therapy (204) 204
in-vitro (204) 204
prospective studies (202) 202
hepatitis c - drug therapy (200) 200
mortality (198) 198
biomedicine (196) 196
hepatocellular carcinoma (195) 195
plus ribavirin (195) 195
medical research (194) 194
medicine, general & internal (194) 194
gastroenterology and hepatology (193) 193
infection (192) 192
follow-up studies (190) 190
attention - physiology (188) 188
polyethylene glycols - therapeutic use (182) 182
pharmacology/toxicology (181) 181
review (181) 181
infections (180) 180
antiviral agents - adverse effects (179) 179
medicine, research & experimental (177) 177
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5733) 5733
Japanese (19) 19
German (16) 16
French (13) 13
Spanish (12) 12
Korean (9) 9
Russian (4) 4
Portuguese (3) 3
Chinese (2) 2
Persian (2) 2
Afrikaans (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, ISSN 0271-0749, 02/2018, Volume 38, Issue 1, pp. 34 - 41
Purpose/Background It is unclear whether increasing the dose of varenicline beyond the standard dose of 2 mg/d would improve smoking abstinence. Methods We... 
3 mg varenicline | PSYCHIATRY | VALIDATION | SENSITIVITY | smoking abstinence | DISORDERS | NEGATIVE AFFECT | RECEPTOR PARTIAL AGONIST | high dose | CESSATION | DEPENDENCE | NICOTINE PATCH | SMOKERS | PHARMACOLOGY & PHARMACY | cancer | SUSTAINED-RELEASE BUPROPION | Index Medicus | 3 mg | Varenicline
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 07/2019, Volume 71, Issue 7, pp. 1044 - 1054
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 10/2015, Volume 42, Issue 7, pp. 889 - 901
Summary Background Successful antiviral treatment of decompensated hepatitis B with HBV polymerase inhibitors is associated with improvement of liver function.... 
SUSTAINED VIROLOGICAL RESPONSE | B-VIRUS | MANAGEMENT | CHRONIC HEPATITIS-C | PHARMACOLOGY & PHARMACY | VIRUS GENOTYPE 1 | INFECTION | RIBAVIRIN | GASTROENTEROLOGY & HEPATOLOGY | DACLATASVIR PLUS SOFOSBUVIR | LEDIPASVIR | Hepatitis C, Chronic - pathology | Liver - pathology | Humans | Middle Aged | Hepatitis C, Chronic - physiopathology | Male | Liver - physiopathology | Simeprevir - therapeutic use | Liver Cirrhosis - diagnostic imaging | Liver - drug effects | Liver - diagnostic imaging | Ultrasonography | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Liver Function Tests | Sofosbuvir - therapeutic use | Liver Cirrhosis - drug therapy | Antiviral Agents - therapeutic use | Hepatitis C, Chronic - diagnostic imaging | Ribavirin - therapeutic use | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Liver Cirrhosis - virology | Liver Cirrhosis - pathology | Aged | Liver Cirrhosis - physiopathology | Cohort Studies | Medical examination | Thrombin | Interferon | Bilirubin | Biological response modifiers | Hepatitis C virus | Hepatitis C | Liver cirrhosis | Blood | Parameters | Syngeneic grafts | Liver | Ribonucleic acid--RNA | Patients | Ribavirin | Cholinesterase | Polymerase | Hepatitis | Cirrhosis | Allografts | Prothrombin | Kinetics | Hepatitis B virus | Genotypes | Hepatitis B | Liver transplantation
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 12/2017, Volume 32, Issue 12, pp. 1982 - 1988
Journal Article
Journal Article
Plastic and Reconstructive Surgery, ISSN 0032-1052, 10/2019, Volume 144, Issue 4, pp. 869 - 880
BACKGROUND:The efficacy of autologous fat transplantation is reduced by fat absorption and fibrosis that are closely related to unsatisfactory vascularization.... 
SURVIVAL | SURGERY | M2 MACROPHAGES | IN-VITRO | REGENERATION | ASSISTED LIPOTRANSFER | TISSUE | EXOSOMES | MICROVESICLES | SUSTAINED-RELEASE | TRANSPLANTATION
Journal Article
Liver International, ISSN 1478-3223, 01/2019, Volume 39, Issue 1, pp. 54 - 59
Journal Article